The bumpy road to drug pricing reform continues as the US Most Favored Nation deadline of September 29th faces delays. Regulatory complexities, competing healthcare priorities like the Strategic API Reserve, and election year politics are all...
The pharmaceutical industry faces a transformative shift as drug pricing pressures intensify in the US market, with the September 29 deadline approaching for companies to implement Most Favored Nation pricing. Marketing strategies must evolve from...
Digital companions are revolutionizing the post-prescription landscape, turning traditional patient support upside down. Cathy Zaremba, Senior Director of Marketing at Medisafe, reveals how personalized, data-driven platforms are transforming...
The pharmaceutical landscape is shifting dramatically beneath our feet. With the US government recently demanding drug price reductions of up to 60% from major pharma companies or face potential reimbursement restrictions, the industry faces what...
Test Out an AI Voice Agent Call at MedisafeVIA.com The healthcare landscape is being reshaped by a powerful new tool: AI voice agents. These conversational companions are addressing one of healthcare’s most persistent challenges – medication...
The healthcare technology landscape is undergoing a profound transformation with a White House-led initiative dubbed “Make Health Technology Great Again” that aims to create a streamlined approach to health data sharing through a...
Digital health expectations are becoming the new baseline in healthcare as patients increasingly expect the same level of convenience they experience in other aspects of their digital lives. The disconnect between modern consumer expectations and...
AstraZeneca is committing a staggering $50 billion into U.S. operations, encompassing R&D, manufacturing, and supply chain expansion by 2030. This is one of the largest US pharma infrastructure investments in recent history. Pfizer and Moderna...
What defines truly effective digital health technology in today’s healthcare landscape? According to Brian Carr, SVP of Marketing at Medisafe, the answer is refreshingly straightforward: patient engagement. When seven out of ten users...
A seismic shift may be approaching the pharmaceutical industry with US administration statements suggesting pharmaceutical import tariffs could reach a staggering 250 percent. This isn’t just another policy headline – it represents a potential...